Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0006142,
umls-concept:C0008976,
umls-concept:C0024881,
umls-concept:C0035020,
umls-concept:C0038952,
umls-concept:C0039694,
umls-concept:C0087111,
umls-concept:C0205276,
umls-concept:C0441766,
umls-concept:C0442967,
umls-concept:C1274040,
umls-concept:C1516985,
umls-concept:C1521761,
umls-concept:C1707455,
umls-concept:C2347858
|
pubmed:issue |
4-5
|
pubmed:dateCreated |
1992-10-19
|
pubmed:abstractText |
A (modified) radical mastectomy (RM) was compared with breast-conserving therapy (BCT) in stage I and stage II breast cancer patients. Treatment of the study arm comprised lumpectomy, axillary clearance and radiotherapy to the breast (50 Gy in 5 weeks external irradiation and a boost with iridium implant of 25 Gy). 902 patients were included. There were 734 TNM stage II patients. Patients with microscopically incomplete excision of the tumour were not excluded. After a median follow-up of 6 years, overall survival and local recurrence rates do not differ significantly between the two study arms. Actuarial survival at 8 years was 73% after RM and 71% after BCT; actuarial local recurrence at 8 years was 9% and 15%, respectively. In the mastectomy group tumour size did not affect local relapse, but after BCT the incidence of local recurrences was higher for tumours of 2-5 cm (16%) than for smaller tumours (7%) (at 8 years, P = 0.08). Results of salvage treatment for local recurrence so far were similar in both the BCT and the mastectomy group.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
801-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1524898-Aging,
pubmed-meshheading:1524898-Breast Neoplasms,
pubmed-meshheading:1524898-Combined Modality Therapy,
pubmed-meshheading:1524898-Female,
pubmed-meshheading:1524898-Follow-Up Studies,
pubmed-meshheading:1524898-Humans,
pubmed-meshheading:1524898-Incidence,
pubmed-meshheading:1524898-Mastectomy, Modified Radical,
pubmed-meshheading:1524898-Mastectomy, Segmental,
pubmed-meshheading:1524898-Middle Aged,
pubmed-meshheading:1524898-Neoplasm Metastasis,
pubmed-meshheading:1524898-Neoplasm Recurrence, Local,
pubmed-meshheading:1524898-Neoplasm Staging,
pubmed-meshheading:1524898-Prognosis,
pubmed-meshheading:1524898-Salvage Therapy,
pubmed-meshheading:1524898-Time Factors
|
pubmed:year |
1992
|
pubmed:articleTitle |
Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
|
pubmed:affiliation |
Department of Surgery, The Netherlands Cancer Institute, Amsterdam.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|